This contract is for the supply of two specific pharmaceutical products: Palonosetron and Ondansetron. The contract is a framework agreement, which means it establishes the terms and conditions for future orders of these medications. The buyer is the Central Negotiation for Hospital Purchases in Bel
Tender closed on 7 Oct 2025. Awaiting award.
Mostly framework call-offs rather than head-to-head competition.
In healthcare medical, CENTRAL NEGOTIATION FOR HOSPITAL PURCHASES has awarded 1 contract to 1 supplier.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.
